Epilepsy Action’s letters to the new government

83 residents needing homes after care home closure

Pharmaceutical companies fined £70 million

Grant secured for bilingual therapy service

Lack of care plans and access to specialists

Fenfluramine recommended for use in Dravet syndrome

Have your say about the cost-of-living crisis

People with epilepsy eligible for autumn booster

Left in the dark